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Abstract 
Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation, 
malignant triton tumor, has a rare incidence. We report such a case in a 40-year-old male 
who presented with a mass over the buttock. He was a previously diagnosed case of 
neurofibroma in the same area. Histomorphology supported by immunostaining with 
S-100 protein confirmed the diagnosis. Malignant triton tumor has a poor prognosis 
owing to its aggressive biological behavior. The fact that the presence of this tumor in 
the buttock region is extremely rare has prompted the authors to report this case. 
 
Introduction 
Malignant peripheral nerve sheath tumor (MPNST) accounts for about 5–10% of all 
soft tissue sarcomas [1]. Malignant triton tumor (MTT) constitutes about 5% of all 
MPNSTs [2]. MTT is commonly seen in the head, neck, extremities and trunk [1–3]. 
Other rare locations are the buttock, visceras, retroperitoneum and mediastinum. 
Intracranial locations include the parieto-occipital lobe, lateral ventricle and 
cerebellopontine angle [1–3]. The fact that the presence of this tumor in the buttock 
region is extremely rare has prompted the authors to report this case. This is an 
interesting tumor not encountered very much in the neuro-oncology literature. It can 
occur in sporadic form or over a setting of neurofibromatosis-1 (NF-1). When MTT 
develops over NF-1, the diagnosis can be confirmed based on morphologic grounds 
supported by an immunostain such as S-100 protein. Desmin, myo-D1 and myogenin are 
immunostains positive for rhabdomyoblasts [2]. MTT has an aggressive biological 
behavior. Modern treatment has improved the prognosis of such cases [3].  
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Case Report 
A 40-year-old male presented with a large mass in the gluteal region gradually increasing in size over 
6 months. Ten years back, operation of a nodule in the same area had revealed histopathological 
diagnosis of neurofibroma. On further questioning, the patient revealed having two small painful 
nodules over his back since the presence of the operated nodule. His family history suggested that his 
father was a diagnosed case of von Recklinghausen disease (NF-1). The resected mass consisted of a 
large globular mass measuring 10 × 7 × 6 cm. The cut section showed solid grey-white and hemorrhagic 
areas (fig. 1). Multiple sections studied revealed alternate hypocellular and hypercellular areas 
composed of spindle cells with wavy nucleus and nuclear palisading. Thick-walled blood vessels were 
seen with perivascular accentuation of tumor cells in the hypocellular areas (fig. 2). Mitotic figures were 
brisk in the cellular areas, 11/10 high power fields with few abnormal mitoses. The tumor also showed a 
good number of scattered large cells both rounded and elongated with abundant deep eosinophilic 
cytoplasm and clearly visible cross striations (fig. 3). The spindle cells showed focal positivity for S-100 
protein. The patient was subjected to radiotherapy on being referred to the oncology department. 
During a follow-up period of 8 months, the patient showed no evidence of recurrence or metastasis. 
Discussion 
MTT arises in two principal forms: sporadic or in association with NF-1. Slightly 
more than half of the cases of MTT have been reported in conjunction with NF-1 [1–3]. 
In our case, the tumor developed over a setting of NF-1. When it occurs in sporadic form, 
other spindle cell sarcomas like fibrosarcoma, malignant fibrous histiocytoma and 
rhabdomyosarcoma can come as differential diagnosis [3]. MTT with NF-1 shows marked 
male predominance with more predilections for younger age groups. The sporadic forms 
are seen in females of older age groups [4]. The tumor develops after a long latent period 
of 10–20 years. In our case the tumor developed after 10 years [1–4]. 
There is an agreement that the diagnosis of MPNST can be on morphologic grounds 
supported by positivity for S-100 protein. The morphologic features are (a) alternating 
hypocellular and hypercellular regions, (b) the appearance of thin wavy comma-shaped/ 
bullet-shaped nucleus in the hypocellular areas, (c) presence of nuclear palisading, 
(d) presence of nerve whorls or tactoid bodies resembling Wagner-Meissner corpuscles, 
(e) prominent thick-walled vasculature, and (f) presence of heterologous elements like 
rhabdomyoblasts, cartilage and bone. Such tumors show focal positivity for S-100 protein 
in 50–90% of cases, suggesting a nerve sheath origin. Rhabdomyoblasts are positive for 
immunostains such as desmin, myogenin and myo-D1 [1–4]. 
MTTs are tumors with a poor prognosis. The 5-year survival rate of MTTs is only  
5–15% in contrast to MPNSTs where it is 50–60% [5]. Modern treatment has improved 
the prognosis of such cases. Radical excision followed by high-dose radiotherapy is the 
conventional mode of treatment. Some recent reports suggest that neoadjuvant therapy 
and adjuvant chemotherapy can eradicate micrometastasis. Integrated positron emission 
tomography and computed tomography have been used to assess remission and response 
to therapy [6]. The prognosis of MTT depends on the location, grade and completeness of 
surgical margins. It is good for the head, neck, extremities and worse for other sites 
including the buttock [7]. In a study it was observed that MTT in association with NF-1 
has a poor prognosis compared to sporadic forms [3–7]. 
Recent works on cytogenetics have revealed some karyotypic changes associated with 
this tumor. There is a breakpoint in 11p15, considered a region of myogenic 
differentiation. This gene is probably responsible for rhabdomyoblastic differentiation. 
Amplification of c-myc oncogene is probably responsible for its aggressive biologic 
behavior [8].  
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Fig. 1. Photograph of the cut open tumor mass measuring 10 × 7 × 6 cm with solid grey-white and 
hemorrhagic areas. 
 
 
 
Fig. 2. Pictomicrograph showing hypocellular areas of the tumor with spindle cells having wavy 
nucleus, thick-walled blood vessels, perivascular accentuation of tumor cells and few rhabdomyoblasts. 
H&E, ×200. 
 
 
  
Case Rep Neurol 2010;2:69–73 
DOI: 10.1159/000315621 
Published online: June 1, 2010  © 2010 S. Karger AG, Basel 
ISSN 1662–680X 
www.karger.com/crn 
 
 
72
Fig. 3. Pictomicrograph of the tumor showing both elongated and rounded rhabdomyoblastic cells. 
H&E, ×400. 
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